BIOGEN INC. Goodwill, Other Increase (Decrease)
BIOGEN INC. (BIIB) reported Goodwill, Other Increase (Decrease) of -$2.40 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillOtherIncreaseDecrease · last filed 2026-04-29
- BIOGEN INC. goodwill, other increase (decrease) for the quarter ending 2026-03-31 was -$2.40M, a 172.73% decline year-over-year.
- BIOGEN INC. goodwill, other increase (decrease) for the quarter ending 2025-12-31 was $400.00K.
- BIOGEN INC. goodwill, other increase (decrease) for the quarter ending 2025-09-30 was -$2.40M, a 138.71% decline year-over-year.
- BIOGEN INC. goodwill, other increase (decrease) for the quarter ending 2025-06-30 was $6.40M.
- BIOGEN INC. goodwill, other increase (decrease) for fiscal 2025 was $7.70M.
- BIOGEN INC. goodwill, other increase (decrease) for fiscal 2024 was -$1.50M, a 126.32% decline from fiscal 2023.
- BIOGEN INC. goodwill, other increase (decrease) for fiscal 2023 was $5.70M.
- BIOGEN INC. goodwill, other increase (decrease) for fiscal 2022 was -$12.10M.
| Period end | Goodwill, Other Increase (Decrease) 3 month | Goodwill, Other Increase (Decrease) 6 month | Goodwill, Other Increase (Decrease) 9 month | Goodwill, Other Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$2.40M 10-Q · filed 2026-04-29 | -$2.00M derived: sum of 2 quarters · filed 2026-04-29 | -$4.40M derived: sum of 3 quarters · filed 2026-04-29 | $2.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$2.00M derived: sum of 2 quarters · filed 2026-02-06 | $4.40M derived: sum of 3 quarters · filed 2026-02-06 | $7.70M 10-K · filed 2026-02-06 |
| 2025-09-30 | -$2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $4.00M derived: sum of 2 quarters · filed 2025-10-30 | $7.30M 10-Q · filed 2025-10-30 | $400.00K derived: sum of 4 quarters · filed 2026-02-06 |
| 2025-06-30 | $6.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $9.70M 10-Q · filed 2025-07-31 | $2.80M derived: sum of 3 quarters · filed 2026-02-06 | $9.00M derived: sum of 4 quarters · filed 2026-02-06 |
| 2025-03-31 | $3.30M 10-Q · filed 2025-05-01 | -$3.60M derived: sum of 2 quarters · filed 2026-02-06 | $2.60M derived: sum of 3 quarters · filed 2026-02-06 | $2.60M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-12-31 | -$6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$700.00K derived: sum of 2 quarters · filed 2026-02-06 | -$700.00K derived: sum of 3 quarters · filed 2026-02-06 | -$1.50M 10-K · filed 2026-02-06 |
| 2024-09-30 | $6.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $6.20M derived: sum of 2 quarters · filed 2024-10-30 | $5.40M 10-Q · filed 2024-10-30 | $9.90M derived: sum of 4 quarters · filed 2025-02-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$800.00K 10-Q · filed 2024-08-01 | $3.70M derived: sum of 3 quarters · filed 2025-02-12 | $200.00K derived: sum of 4 quarters · filed 2025-02-12 |
| 2024-03-31 | -$800.00K 10-Q · filed 2024-04-24 | $3.70M derived: sum of 2 quarters · filed 2025-02-12 | $200.00K derived: sum of 3 quarters · filed 2025-02-12 | $2.10M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.00M derived: sum of 2 quarters · filed 2025-02-12 | $2.90M derived: sum of 3 quarters · filed 2025-02-12 | $5.70M 10-K · filed 2025-02-12 |
| 2023-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.60M derived: sum of 2 quarters · filed 2023-11-08 | $1.20M 10-Q · filed 2023-11-08 | $9.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | $4.70M 10-Q · filed 2023-07-25 | $12.50M derived: sum of 3 quarters · filed 2024-02-14 | $4.10M derived: sum of 4 quarters · filed 2024-02-14 |
| 2023-03-31 | $2.80M 10-Q · filed 2023-04-25 | $10.60M derived: sum of 2 quarters · filed 2024-02-14 | $2.20M derived: sum of 3 quarters · filed 2024-02-14 | -$6.20M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$600.00K derived: sum of 2 quarters · filed 2024-02-14 | -$9.00M derived: sum of 3 quarters · filed 2024-02-14 | -$12.10M 10-K · filed 2024-02-14 |
| 2022-09-30 | -$8.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$16.80M derived: sum of 2 quarters · filed 2022-10-25 | -$19.90M 10-Q · filed 2022-10-25 | -$19.30M derived: sum of 4 quarters · filed 2023-02-15 |
| 2022-06-30 | -$8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-20 | -$11.50M 10-Q · filed 2022-07-20 | -$10.90M derived: sum of 3 quarters · filed 2023-02-15 | -$14.30M derived: sum of 4 quarters · filed 2023-02-15 |
| 2022-03-31 | -$3.10M 10-Q · filed 2022-05-03 | -$2.50M derived: sum of 2 quarters · filed 2023-02-15 | -$5.90M derived: sum of 3 quarters · filed 2023-02-15 | -$5.10M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$2.80M derived: sum of 2 quarters · filed 2023-02-15 | -$2.00M derived: sum of 3 quarters · filed 2023-02-15 | -$1.00M 10-K · filed 2023-02-15 |
| 2021-09-30 | -$3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20 | -$2.60M derived: sum of 2 quarters · filed 2021-10-20 | -$1.60M 10-Q · filed 2021-10-20 | $4.80M derived: sum of 4 quarters · filed 2022-02-03 |
| 2021-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-22 | $1.80M 10-Q · filed 2021-07-22 | $8.20M derived: sum of 3 quarters · filed 2022-02-03 | $12.90M derived: sum of 4 quarters · filed 2022-02-03 |
| 2021-03-31 | $1.00M 10-Q · filed 2021-04-22 | $7.40M derived: sum of 2 quarters · filed 2022-02-03 | $12.10M derived: sum of 3 quarters · filed 2022-02-03 | $11.10M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $11.10M derived: sum of 2 quarters · filed 2022-02-03 | $10.10M derived: sum of 3 quarters · filed 2022-02-03 | $4.30M 10-K · filed 2022-02-03 |
| 2020-09-30 | $4.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-21 | $3.70M derived: sum of 2 quarters · filed 2020-10-21 | -$2.10M 10-Q · filed 2020-10-21 | $4.70M derived: sum of 4 quarters · filed 2021-02-03 |
| 2020-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-22 | -$6.80M 10-Q · filed 2020-07-22 | $0.00 derived: sum of 3 quarters · filed 2021-02-03 | -$3.10M derived: sum of 4 quarters · filed 2021-02-03 |
| 2020-03-31 | -$5.80M 10-Q · filed 2020-04-23 | $1.00M derived: sum of 2 quarters · filed 2021-02-03 | -$2.10M derived: sum of 3 quarters · filed 2021-02-03 | -$5.20M derived: sum of 4 quarters · filed 2021-02-03 |
| 2019-12-31 | $6.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $3.70M derived: sum of 2 quarters · filed 2021-02-03 | $600.00K derived: sum of 3 quarters · filed 2021-02-03 | $3.40M 10-K · filed 2021-02-03 |
| 2019-09-30 | -$3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$6.20M derived: sum of 2 quarters · filed 2019-10-22 | -$3.40M 10-Q · filed 2019-10-22 | -$6.50M derived: sum of 4 quarters · filed 2020-02-06 |
| 2019-06-30 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$300.00K 10-Q · filed 2019-07-24 | -$3.40M derived: sum of 3 quarters · filed 2020-02-06 | -$3.40M derived: sum of 4 quarters · filed 2020-02-06 |
| 2019-03-31 | $2.80M 10-Q · filed 2019-04-24 | -$300.00K derived: sum of 2 quarters · filed 2020-02-06 | -$300.00K derived: sum of 3 quarters · filed 2020-02-06 | -$8.20M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$3.10M derived: sum of 2 quarters · filed 2020-02-06 | -$11.00M derived: sum of 3 quarters · filed 2020-02-06 | -$6.20M 10-K · filed 2020-02-06 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | -$7.90M derived: sum of 2 quarters · filed 2018-10-23 | -$3.10M 10-Q · filed 2018-10-23 | -$3.00M derived: sum of 4 quarters · filed 2019-02-06 |
| 2018-06-30 | -$7.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-24 | -$3.10M 10-Q · filed 2018-07-24 | -$3.00M derived: sum of 3 quarters · filed 2019-02-06 | $600.00K derived: sum of 4 quarters · filed 2019-02-06 |
| 2018-03-31 | $4.80M 10-Q · filed 2018-04-24 | $4.90M derived: sum of 2 quarters · filed 2019-02-06 | $8.50M derived: sum of 3 quarters · filed 2019-02-06 | $13.00M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $3.70M derived: sum of 2 quarters · filed 2019-02-06 | $8.20M derived: sum of 3 quarters · filed 2019-02-06 | $10.00M 10-K · filed 2019-02-06 |
| 2017-09-30 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-24 | $8.10M derived: sum of 2 quarters · filed 2017-10-24 | $9.90M 10-Q · filed 2017-10-24 | $3.90M derived: sum of 4 quarters · filed 2018-02-01 |
| 2017-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $6.30M 10-Q · filed 2017-07-25 | $300.00K derived: sum of 3 quarters · filed 2018-02-01 | -$3.40M derived: sum of 4 quarters · filed 2018-02-01 |
| 2017-03-31 | $1.80M 10-Q · filed 2017-04-25 | -$4.20M derived: sum of 2 quarters · filed 2018-02-01 | -$7.90M derived: sum of 3 quarters · filed 2018-02-01 | -$15.90M derived: sum of 4 quarters · filed 2018-02-01 |
| 2016-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | -$9.70M derived: sum of 2 quarters · filed 2018-02-01 | -$17.70M derived: sum of 3 quarters · filed 2018-02-01 | -$21.40M 10-K · filed 2018-02-01 |
| 2016-09-30 | -$3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-26 | -$11.70M derived: sum of 2 quarters · filed 2016-10-26 | -$15.40M 10-Q · filed 2016-10-26 | |
| 2016-06-30 | -$8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-21 | -$11.70M 10-Q · filed 2016-07-21 | ||
| 2016-03-31 | -$3.70M 10-Q · filed 2016-04-21 | |||
| 2015-12-31 | -$4.50M 10-K · filed 2017-02-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |